Call Options

23 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$187.96 - $245.29 $300,736 - $392,464
1,600 Added 106.67%
3,100 $610,000
Q2 2024

Aug 14, 2024

SELL
$206.39 - $268.73 $412,780 - $537,460
-2,000 Reduced 57.14%
1,500 $309,000
Q1 2024

May 15, 2024

SELL
$203.52 - $273.43 $1.47 Million - $1.97 Million
-7,200 Reduced 67.29%
3,500 $948,000
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $493,560 - $716,520
-3,000 Reduced 21.9%
10,700 $2.53 Million
Q3 2023

Nov 14, 2023

SELL
$194.44 - $217.61 $349,992 - $391,698
-1,800 Reduced 11.61%
13,700 $2.68 Million
Q2 2023

Aug 14, 2023

BUY
$183.71 - $210.25 $936,921 - $1.07 Million
5,100 Added 49.04%
15,500 $3.26 Million
Q1 2023

May 15, 2023

BUY
$191.89 - $259.92 $1.06 Million - $1.43 Million
5,500 Added 112.24%
10,400 $2.1 Million
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $571,619 - $725,203
2,900 Added 145.0%
4,900 $1.07 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $2.28 Million - $3.13 Million
-12,500 Reduced 86.21%
2,000 $394,000
Q2 2022

Aug 08, 2022

BUY
$204.13 - $302.4 $2.8 Million - $4.14 Million
13,700 Added 1712.5%
14,500 $3.1 Million
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $70,276 - $89,736
200 Added 33.33%
800 $301,000
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $1.68 Million - $2.06 Million
-4,500 Reduced 88.24%
600 $248,000
Q1 2021

May 17, 2021

SELL
$249.67 - $299.48 $1.02 Million - $1.23 Million
-4,100 Reduced 44.57%
5,100 $1.48 Million
Q4 2020

Feb 16, 2021

BUY
$222.0 - $252.62 $1.13 Million - $1.29 Million
5,100 Added 124.39%
9,200 $2.3 Million
Q3 2020

Nov 16, 2020

BUY
$175.56 - $226.45 $298,452 - $384,965
1,700 Added 70.83%
4,100 $928,000
Q2 2020

Aug 14, 2020

SELL
$118.84 - $189.72 $23,768 - $37,944
-200 Reduced 7.69%
2,400 $418,000
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $187,910 - $338,846
1,900 Added 271.43%
2,600 $328,000
Q4 2019

Feb 14, 2020

SELL
$126.05 - $152.76 $1.05 Million - $1.27 Million
-8,300 Reduced 92.22%
700 $107,000
Q3 2019

Nov 14, 2019

SELL
$125.07 - $143.67 $212,619 - $244,238
-1,700 Reduced 15.89%
9,000 $1.19 Million
Q2 2019

Aug 14, 2019

SELL
$123.4 - $148.55 $283,820 - $341,665
-2,300 Reduced 17.69%
10,700 $1.52 Million
Q1 2019

May 15, 2019

SELL
$104.82 - $146.73 $1.33 Million - $1.86 Million
-12,700 Reduced 49.42%
13,000 $1.89 Million
Q4 2018

Feb 14, 2019

BUY
$105.09 - $137.23 $588,504 - $768,488
5,600 Added 27.86%
25,700 $2.91 Million
Q3 2018

Nov 14, 2018

BUY
$112.11 - $134.54 $2.25 Million - $2.7 Million
20,100 New
20,100 $2.7 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.